Contact Us
Drug Search Results
More Filters [+]

Lumiracoxib

Alternative Names: lumiracoxib
Latest Update: 2024-03-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: COX2 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Chile | Colombia | Dominican Republic | Germany | India | New Zealand | Norway | Peru | Portugal | Slovenia | Sweden | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Novartis
Company Location: BASEL V8 CH 4056
Company CEO: Vasant Narasimhan
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lumiracoxib

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Osteoarthritis|Acute Pain|Hypertension|Pain Unspecified|Healthy Volunteers|Musculoskeletal Pain

Phase 3: Osteoarthritis|Arthritis, Rheumatoid|Osteoarthritis, Knee|Osteoarthritis, Hip|Pain Unspecified

Phase 2: Kidney Failure, Chronic|Arthralgia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2006-7041-83/hah

N/A

Not yet recruiting

Pregnancy Outcomes

2019-12-01

PEMEX-805415-00-2

P2

Terminated

Kidney Failure, Chronic|Arthralgia

2012-11-01

ND

P4

Completed

Unknown

2010-10-16

2005-005949-19

P3

Completed

Pain Unspecified

2006-12-15

Recent News Events

Date

Type

Title

03/01/2024

PubMed

 Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations.

01/01/2024

PubMed

 Unveiling the therapeutic promise of natural products in alleviating drug-induced liver injury: Present advancements and future prospects.

11/23/2023

PubMed

 Bioactivity of dihydropyrimidinone derivatives as inhibitors of cyclooxygenase-2 (COX-2): an in silico approach.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions